Publications by authors named "Nobuto Okamoto"

Purpose: Postoperative cholangitis and anastomotic strictures (AS) are long-term complications of biliary-enteric anastomosis (BEA).

Methods: We retrospectively reviewed data of patients who underwent bile duct resection with or without hepatectomy and investigated the risk factors for postoperative cholangitis, benign AS, and incidence of Clavien-Dindo (C-D) Grade III complications.

Results: Overall, data of 189 patients (115 men and 74 women) were retrospectively analyzed.

View Article and Find Full Text PDF

Survival remains poor even after resection of pancreatic cancer and the postoperative recurrence rate is extremely high. Thus, neoadjuvant treatment may improve outcomes for resectable pancreatic cancer (RPC). This study evaluated the efficacy of neoadjuvant therapy for radiologically judged RPC.

View Article and Find Full Text PDF

Objective: Nonalcoholic fatty liver disease (NAFLD) is often associated with insulin resistance and glucose intolerance. Postprandial hypoglycemia frequently occurs in NAFLD patients; however, the details remain unclear.

Patients And Methods: The 75-g oral glucose tolerance test (75gOGTT) in 502 patients with biopsy-proven NAFLD and continuous glucose monitoring (CGM) in 20 patients were performed, and the characteristics and causes of postprandial hypoglycemia were investigated.

View Article and Find Full Text PDF
Article Synopsis
  • * In NAFLD patients, higher blood glucose levels and fluctuations correlated with markers of liver scarring (fibrosis), indicating a gradual worsening of glucose intolerance as liver damage progresses.
  • * In contrast, C-CH patients showed that rising blood glucose levels were linked to lower serum albumin levels, suggesting glucose intolerance emerged suddenly when albumin levels dropped below a certain threshold.
View Article and Find Full Text PDF
Article Synopsis
  • Insulin resistance and type 2 diabetes are linked to worsening non-alcoholic fatty liver disease (NAFLD), but how glucose metabolism affects liver damage severity in pre-diabetic patients isn't well understood.
  • A study of 103 NAFLD patients without prior diabetes found that fasting insulin levels were a key predictor of severe liver fibrosis (F3).
  • High fasting insulin levels, specifically above 13.2 μU/mL, were determined to significantly indicate greater liver damage in these patients, highlighting the importance of insulin in assessing liver health before diabetes develops.*
View Article and Find Full Text PDF

Aim: Non-alcoholic steatohepatitis (NASH) is the major cause of chronic liver disease worldwide. Endoplasmic reticulum (ER) stress is considered to be an important pathological characteristic in NASH. A sequence variation (I148M) in the patatin-like phospholipase domain-containing protein 3/adiponutrin (PNPLA3) gene is known to be associated with the development of NASH.

View Article and Find Full Text PDF

Unlabelled: Patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) often have metabolic disorders including insulin resistance and type 2 diabetes mellitus (T2DM). We clarified the predictive factors in glucose metabolism for progression of hepatic fibrosis in patients with NAFLD by the 75-g oral glucose tolerance test (75gOGTT) and a continuous glucose monitoring system (CGMS). One hundred sixty-nine patients (68 female and 101 male patients) with biopsy-proven NAFLD with performance with 75gOGTT were enrolled and divided into four groups according to the stage of hepatic fibrosis (F0-3).

View Article and Find Full Text PDF

Background: Obesity-induced liver disease (nonalcoholic fatty liver disease, NAFLD) is now the commonest cause of chronic liver disease in affluent nations. There are presently no proven treatments for NAFLD or its more severe stage, nonalcoholic steatohepatitis (NASH). Bofutsushosan (BTS), a Japanese herbal (Kampo) medicine, long used as an anti-obesity medicine in Japan and other Asian countries, has been shown to reduce body weight and improve insulin resistance (IR) and hepatic steatosis.

View Article and Find Full Text PDF

Aim:   Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease (NAFLD). Therefore, it is important to evaluate disease activity and distinguish NASH from simple steatosis in NAFLD. Technetium-99 m-2-methoxy-isobutyl-isonitrile ((99m) Tc-MIBI) is a lipophilic cation designed for myocardial perfusion scintigraphy in the diagnosis of ischemic heart diseases, and its retention reflects mitochondrial function.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of the angiotensinogen (AGT) gene haplotype in Japanese patients with non-alcoholic steatohepatitis (NASH) and its relationship to hypertension, a key factor in NASH progression.
  • The researchers analyzed specific single-nucleotide polymorphisms (SNPs) in the AGT gene among 124 NASH patients and 150 healthy controls, finding a significant association between a specific 3-SNP haplotype (CTA) and elevated blood pressure in NASH patients.
  • These findings suggest that targeting the CTA haplotype with medications like ACE inhibitors or angiotensin II type 1 receptor blockers may offer new therapeutic options for managing hypertension in NASH patients.
View Article and Find Full Text PDF

Background: The search for effective treatments of non-alcoholic steatohepatitis (NASH), now the most common chronic liver disease in affluent countries, is hindered by a lack of animal models having the range of anthropometric and pathophysiological features as human NASH.

Aims: To examine if mice treated with gold thioglucose (GTG) - known to induce lesions in the ventromedial hypothalamus, leading to hyperphagia and obesity - and then fed a high-fat diet (HF) had a comprehensive histological and dysmetabolic phenotype resembling human NASH.

Methods: C57BL/6 mice were injected intraperitoneally with GTG and then fed HF for 12 weeks (GTG+HF).

View Article and Find Full Text PDF

Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder characterized by fatty accumulation in the liver without alcohol consumption. NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which may progress to end-stage liver disease. The prevalence of NAFLD is rising because of an increasing prevalence of obesity and metabolic syndrome.

View Article and Find Full Text PDF

Background: Intraductal papillary mucinous neoplasms (IPMN) are a clinicopathological entity that is being diagnosed with increasing frequency. However, the best approach to medical management of IPMN needs to be clarified. The aim of the present study was to identify preoperative features that may be predictors of malignant IPMN, and to define the medical management of IPMN of the pancreas.

View Article and Find Full Text PDF

Three isoforms of carbonic anhydrase-related protein (CA-RP) are evolutionally well conserved among the CA gene family but lack classical CA activity. Although the biological function of CA-RPs is unknown, overexpression of CA-RP VIII has been reported in certain tumor types. Based on the finding that CA-RPs are commonly expressed in the neuronal cells, we investigated expression of all three CA-RPs in gastrointestinal stromal tumor (GIST).

View Article and Find Full Text PDF

Intraductal papillary-mucinous tumor of the pancreas is occasionally accompanied by biliopancreatic fistula. However, it is difficult to show the inflow of mucin produced by the tumor into the common bile duct. To confirm the biliopancreatic fistula, the mucin-rich fraction was purified from the bile and stained with antimucin antibodies.

View Article and Find Full Text PDF

Context: A serum antibody to carbonic anhydrase II has been reported in patients with Sjögren's syndrome and idiopathic chronic pancreatitis.

Objective: To evaluate cellular immune response to carbonic anhydrase II in patients with Sjögren's syndrome and idiopathic chronic pancreatitis.

Patients: Idiopathic chronic pancreatitis (n=23), Sjögren's syndrome (n=12), alcoholic chronic pancreatitis (n=3) and normal controls (n=13).

View Article and Find Full Text PDF

Carbonic anhydrase-related protein (CA-RP VIII) lacks a Zn-binding motif which is essential for carbonic anhydrase activity. Therefore, CA-RP VIII is believed to have a no catalytic activity and a new biological property. In the present study, CA-RP VIII expression in non-tumorous lung and non-small cell lung carcinomas was investigated.

View Article and Find Full Text PDF